A research and development program focused on discovering novel compounds for sEH inhibition and advancing pharmacological, efficacy and toxicity evaluations, as well as patent applications. Through joint research with external institutions including Kyushu University and Tohoku University, the program aims to expand the indications for TMS-008 and pursue applications in new disease areas.